| Identification | Back Directory | [Name]
Benzoic acid, 4-[[[(3'S,4'R,5'S)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'',2''-dihydro-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-[3H]indol]-5'-yl]carbonyl]amino]- | [CAS]
1410738-90-7 | [Synonyms]
Benzoic acid, 4-[[[(3'S,4'R,5'S)-6''-chloro-4'-(3-chloro-2-fluorophenyl)-1'',2''-dihydro-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-[3H]indol]-5'-yl]carbonyl]amino]- | [Molecular Formula]
C30H26Cl2FN3O4 | [MOL File]
1410738-90-7.mol | [Molecular Weight]
582.45 |
| Hazard Information | Back Directory | [Uses]
(S,R,S)-MI-1061 is the isomer of MI-1061(HY-125858). (S,R,S)-MI-1061 can used to synthesize Antibody-Drug Conjugates (ADCs). MI-1061 is a potent, orally bioavailable, and chemically stable MDM2 (MDM2-p53 interaction) inhibitor (IC50=4.4 nM; Ki=0.16 nM). MI-1061 potently activates p53 and induces apoptosis in the SJSA-1 xenograft tumor tissue in mice. Anti-tumor activity[1]. | [References]
[1] Nathan FISHKIN, et al. Linkers for use in antibody drug conjugates. WO2023037268A1. |
|
|